Nina Kupper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nina Kupper has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Johan Denollet
CoRPS - Center of Research on Psychology in Somatic Diseases, Tilburg University, The Netherlands
5 shared publications- Johan Denollet
Tilburg University
5 shared publications - Aline J. Pelle
Department of Medical Psychology and Clinical Psychology, CoRPS-Center of Center of Research on Psychology in Somatic Diseases, Tilburg University, Tilburg, The Netherlands
2 shared publications Dorret I. Boomsma
2 shared publications- Eco J. C. de Geus
Department of Biological Psychology, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
2 shared publications - Gonneke Willemsen
Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
2 shared publications
Latest Publications
- 1 March 2018
- Published by Oxford University Press (OUP)
Impact of psychological factors on outcomes
This is a forthcoming chapter in ESC CardioMed. Please check back later for the full chapter.
- 1 March 2018
- Published by Oxford University Press (OUP)
Impact of psychological factors on outcomes
This is a forthcoming chapter in ESC CardioMed. Please check back later for the full chapter.
- 21 July 2015
- Vol. 36 (28) , 1783-5
Stress and the heart: the role of type D personality in personalized care.
- 21 July 2015
- Vol. 36 (28) , 1783-5
Stress and the heart: the role of type D personality in personalized care.
- 28 June 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 175 (3) , 560-564
Long-term mortality risk in patients with an implantable cardioverter–defibrillator: Influence of heart rate and QRS duration
- 28 June 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 175 (3) , 560-564
Long-term mortality risk in patients with an implantable cardioverter–defibrillator: Influence of heart rate and QRS duration
- 27 November 2013
- Published by Taylor & Francis in Psychology & Health
- Vol. 29 (5) , 564-582
Depressive symptoms in outpatients with heart failure: Importance of inflammatory biomarkers, disease severity and personality
Objective: Depressive symptoms are highly prevalent in heart failure (HF) patients, however the underlying etiology of depression in HF patients remains yet unclear. Hence, the goal is to examine the relative importance of inflammation, disease severity and personality as predictors of depression in HF patients. Design: Depressive symptoms (Hospital Anxiety and Depression Scale, depression subscale) were assessed at baseline and one-year follow-up in 268 HF patients (75.6% men; mean age = 66.7 ± 8.7). Markers of inflammation (TNFα, sTNFr1, sTNFr2, IL-6 and IL-10), disease severity (e.g. New York Heart Association (NYHA) classification) and personality (Type D personality, loneliness) were assessed at baseline. Results: At baseline, NYHA class, body mass index, educational level, Type D personality and loneliness were significantly associated with depression. Higher NYHA class (B = 2.25; SE = .83), higher educational level (B = 1.41; SE = .48), Type D personality (B = 2.56; SE = .60) and loneliness (B = .19; SE = .05) were also independently associated with higher depression levels at one-year follow-up (all p-values < .005). Inflammation, brain natriuretic peptide and left ventricular ejection fraction were not related to depression over time. Conclusions: Personality factors, but not inflammation, were independent concomitants of depressive symptoms in patients with HF. Gaining more insight into the etiology of depression in HF patients is important in order to identify potential targets for novel interventions.
- 27 November 2013
- Published by Taylor & Francis in Psychology & Health
- Vol. 29 (5) , 564-582
Depressive symptoms in outpatients with heart failure: Importance of inflammatory biomarkers, disease severity and personality
Objective: Depressive symptoms are highly prevalent in heart failure (HF) patients, however the underlying etiology of depression in HF patients remains yet unclear. Hence, the goal is to examine the relative importance of inflammation, disease severity and personality as predictors of depression in HF patients. Design: Depressive symptoms (Hospital Anxiety and Depression Scale, depression subscale) were assessed at baseline and one-year follow-up in 268 HF patients (75.6% men; mean age = 66.7 ± 8.7). Markers of inflammation (TNFα, sTNFr1, sTNFr2, IL-6 and IL-10), disease severity (e.g. New York Heart Association (NYHA) classification) and personality (Type D personality, loneliness) were assessed at baseline. Results: At baseline, NYHA class, body mass index, educational level, Type D personality and loneliness were significantly associated with depression. Higher NYHA class (B = 2.25; SE = .83), higher educational level (B = 1.41; SE = .48), Type D personality (B = 2.56; SE = .60) and loneliness (B = .19; SE = .05) were also independently associated with higher depression levels at one-year follow-up (all p-values < .005). Inflammation, brain natriuretic peptide and left ventricular ejection fraction were not related to depression over time. Conclusions: Personality factors, but not inflammation, were independent concomitants of depressive symptoms in patients with HF. Gaining more insight into the etiology of depression in HF patients is important in order to identify potential targets for novel interventions.
- 1 August 2013
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 75 (2) , 197-198
Recent progress in understanding the clinical concept of Type D
- 1 August 2013
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 75 (2) , 197-198
Recent progress in understanding the clinical concept of Type D
- 1 February 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 136 (3) , 567-576
Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients
- 1 February 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 136 (3) , 567-576
Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients
- 1 February 2012
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 26 (2) , 301-310
Type D personality and course of health status over 18 months in outpatients with heart failure: Multiple mediating inflammatory biomarkers
- 1 February 2012
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 26 (2) , 301-310
Type D personality and course of health status over 18 months in outpatients with heart failure: Multiple mediating inflammatory biomarkers
- 1 January 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 136 (1-2) , 90-98
Social anxiety in the general population: Introducing abbreviated versions of SIAS and SPS
- 1 January 2012
- Published by Elsevier in Journal of Affective Disorders
- Vol. 136 (1-2) , 90-98
Social anxiety in the general population: Introducing abbreviated versions of SIAS and SPS
- Open Access
- 14 October 2011
- Published by Springer Nature in Trials
- Vol. 12 (1) , 227
Investigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial
Background: Frequent rehospitalisations and poorer survival chances in heart failure (HF) patients may partly be explained by poor medication adherence. There are multiple medication-related reasons for suboptimal adherence, but psychological reasons may also be important. A novel TELEmonitoring device may improve MEDication adherence in HF patients (TELEMED-HF). TELEMED-HF is a randomized, controlled clinical intervention trial designed to examine (1) the efficacy and cost-efficiency of an electronic medication adherence support system in improving and monitoring HF patients' medication adherence; (2) the effect of medication adherence on hospitalizations and health care consumption; as well as on (3) clinical characteristics, and Quality of Life (QoL); and (4) clinical, sociodemographic, and psychological determinants of medication adherence. Methods/Design: Consecutive patients with chronic, systolic HF presenting to the outpatient clinic of the TweeSteden Hospital, The Netherlands, will be approached for study participation and randomly assigned (1:1) following blocked randomization procedures to the intervention (n = 200) or usual care arm (n = 200). Patients in the intervention arm use the medication support device for six months in addition to usual care. Post-intervention, patients return to usual care only and all patients participate in four follow-up occasions over 12 months. Primary endpoints comprise objective and subjective medication adherence, healthcare consumption, number of hospitalizations, and cost-effectiveness. Secondary endpoints include disease severity, physical functioning, and QoL. Discussion: The TELEMED-HF study will provide us a comprehensive understanding of medication adherence in HF patients, and will show whether telemonitoring is effective and cost-efficient in improving adherence and preventing hospitalization in HF patients. Trial registration number: NCT01347528.
- 14 October 2011
- Published by Springer Nature in Trials
- Vol. 12 (1) , 227
Open AccessInvestigating a TELEmedicine solution to improve MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial
Background: Frequent rehospitalisations and poorer survival chances in heart failure (HF) patients may partly be explained by poor medication adherence. There are multiple medication-related reasons for suboptimal adherence, but psychological reasons may also be important. A novel TELEmonitoring device may improve MEDication adherence in HF patients (TELEMED-HF). TELEMED-HF is a randomized, controlled clinical intervention trial designed to examine (1) the efficacy and cost-efficiency of an electronic medication adherence support system in improving and monitoring HF patients' medication adherence; (2) the effect of medication adherence on hospitalizations and health care consumption; as well as on (3) clinical characteristics, and Quality of Life (QoL); and (4) clinical, sociodemographic, and psychological determinants of medication adherence. Methods/Design: Consecutive patients with chronic, systolic HF presenting to the outpatient clinic of the TweeSteden Hospital, The Netherlands, will be approached for study participation and randomly assigned (1:1) following blocked randomization procedures to the intervention (n = 200) or usual care arm (n = 200). Patients in the intervention arm use the medication support device for six months in addition to usual care. Post-intervention, patients return to usual care only and all patients participate in four follow-up occasions over 12 months. Primary endpoints comprise objective and subjective medication adherence, healthcare consumption, number of hospitalizations, and cost-effectiveness. Secondary endpoints include disease severity, physical functioning, and QoL. Discussion: The TELEMED-HF study will provide us a comprehensive understanding of medication adherence in HF patients, and will show whether telemonitoring is effective and cost-efficient in improving adherence and preventing hospitalization in HF patients. Trial registration number: NCT01347528.
- 1 January 2011
- Published by Wolters Kluwer Health in Psychosomatic Medicine
- Vol. 73 (1) , 75-82
Nine-Year Stability of Type D Personality: Contributions of Genes and Environment
Objective: To assess longitudinal changes in genetic and environmental influences on Type D personality and its subcomponents negative affectivity (NA) and social inhibition (SI) over a 9-year period. Most personality constructs have good retest reliability over long periods, with stability attributed to genes, and changes to environmental factors. Type D personality is stable across an 18-month period and is influenced by genetic factors. However, there is no knowledge on long-term stability, and the contributions of genes and environment to that stability.
- 1 January 2011
- Published by Wolters Kluwer Health in Psychosomatic Medicine
- Vol. 73 (1) , 75-82
Nine-Year Stability of Type D Personality: Contributions of Genes and Environment
Objective: To assess longitudinal changes in genetic and environmental influences on Type D personality and its subcomponents negative affectivity (NA) and social inhibition (SI) over a 9-year period. Most personality constructs have good retest reliability over long periods, with stability attributed to genes, and changes to environmental factors. Type D personality is stable across an 18-month period and is influenced by genetic factors. However, there is no knowledge on long-term stability, and the contributions of genes and environment to that stability.